ELM-PC4_3A | R Documentation |
Kaplan-Meier digitized data from ELM-PC4, figure 3A (PMID 25701170). A reported sample size of 1,560 for a primary endpoint of rPFS/OS in prostate cancer.
`ELM-PC4_3A`
A data frame of 1,560 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (orteronel, placebo) | |
Saad F, Fizazi K, Jinga V, et al. Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. Lancet Oncol 2015; 16: 338–48.
summary(`ELM-PC4_3A`)
kmplot(`ELM-PC4_3A`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.